Incorporation of omega-3 fatty acids

Not Applicable

Completed

• Conditions: Omega-3 fatty acid supplementation; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN18364209
• Lead Sponsor: BASF AS

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33046141/ results (added 14/10/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-12
• Study Completion: 2019-10-31
• Last Update Posted: 27 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Healthy males and females
2. Age 50 to 70 years
3. Body mass index 20 to 35 kg/m2
5. Not eating more than one oily fish meal per week
6. Willing to adhere to the study protocol
7. Able to provide written informed consent
8. Omega-3 index (EPA+DHA in red blood cells) = 6.5 at screening visit

Exclusion Criteria

1. Diabetic (type 1 or type 2)
2. Vegetarian or vegan and unwilling to consume capsules with a beef gelatine coating
3. Use of prescribed medicine to control inflammation
4. Smokers
5. Alcohol consumption > 14 units per week
5. Chronic gastrointestinal problems (e.g. IBD, IBS, celiac disease, cancer)
6. Allergic to fish
7. Use of fish oil or other oil supplement
8. Participation in another clinical trial (currently or in the 12 weeks prior to study entry)
9. Pregnancy or lactation
10. Blood donations during 3 months prior to or during the study period

Study & Design

• Study Type: Interventional
• Study Design: Not specified